✦ LIBER ✦

Phase II study of ifosfamide, etoposide, and oxaliplatin (IFETOx) chemotherapy for relapsed or refractory non-Hodgkin’s lymphoma

✍ Scribed by Seon-Kyeong Kim,Moo-Kon Song,Joo Seop Chung…

Book ID: 126364363
Publisher: Carden Jennings Publishing
Year: 2013
Tongue: English
Weight: 174 KB
Volume: 98
Category: Article
ISSN: 0925-5710
DOI: 10.1007/s12185-013-1440-7

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Ifosfamide, etoposide, cytarabine, and m

Ifosfamide, etoposide, cytarabine, and methotrexate as salvage chemotherapy in relapsed or refractory aggressive non-Hodgkin's lymphoma

✍ Aspasia Stamatoullas; Christophe Fruchart; Dominique Bastit; Dominique Boulet; M 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 567 KB

Treatment of refractory and relapsed non

Treatment of refractory and relapsed non-Hodgkin's lymphoma with ifosfamide, methotrexate and etoposide

✍ Graeme Sangster; W. Nigel Patton; Richard I. Harris; Robert J. Grieve; Michael J 📂 Article 📅 1989 🏛 Springer 🌐 English ⚖ 336 KB

Combination chemotherapy comprising etop

Combination chemotherapy comprising etoposide, mitoxantrone and prednisone effective in refractory or relapsed non-Hodgkin's lymphoma

📂 Article 📅 2000 🏛 Adis International Limited (now part of Wolters Kl ⚖ 133 KB

A multicenter phase II study of darinapa

A multicenter phase II study of darinaparsin in relapsed or refractory Hodgkin's and non-Hodgkin's lymphoma

✍ Peter J. Hosein; Michael D. Craig; Martin S. Tallman; Ralph V. Boccia; Brian L. 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 850 KB

ABVD: doxorubicin,

Phase II study of oxaliplatin in patient

Phase II study of oxaliplatin in patients with recurrent or refractory non-Hodgkin lymphoma

✍ Yasuhiro Oki; Peter McLaughlin; Barbara Pro; Fredrick B. Hagemeister; Archie Ble 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 143 KB 👁 2 views

A multicenter phase II trial of etoposid

A multicenter phase II trial of etoposide, methylprednisolone, high-dose cytarabine, and oxaliplatin for patients with primary refractory/relapsed aggressive non-Hodgkin’s lymphoma

✍ Sun Jin Sym; Dae Ho Lee; Hye Jin Kang; Seung Hyun Nam; Ho Young Kim; Seok Jin Ki 📂 Article 📅 2008 🏛 Springer 🌐 English ⚖ 292 KB